MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-UK-05-0008220
Venor Pharma Limited
Venor Pharma Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹106.47 Cr
▼ 16% YoY
Net profit · FY 2025
₹16.41 Cr
Net margin 15.4%
EBITDA · FY 2025
₹28.39 Cr
EBITDA margin 26.7%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹49.58 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
283
Provident fund records
About Venor Pharma Limited
Data last updated:
Venor Pharma Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2013PLC251565. Its GSTIN is 07AAECV4893M1ZL (Delhi). The company holds 14 GST registrations, of which 10 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Shubham Verma and Yogesh Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 43 Ground Floor G. T. Karnal Road Industrial Area, Delhi, India – 110033.
As per the financials filed for FY 2025, the company reported a revenue of ₹106.47 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹16.41 Cr (net margin 15.4%) and EBITDA of ₹28.39 Cr (EBITDA margin 26.7%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 82% over five years.
The company has about 283 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹49.58 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2023. Its 6 peer companies in the Healthcare industry (Formulations, Preventive Healthcare Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Shiva Biogenetic Pharmaceuticals Private Limited with revenue of ₹107.81 Cr.
Venor Pharma Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-UK-05-0008220). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900DL2013PLC251565
Registration Number 251565
Incorporation Date 03 May 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-UK-05-0008220
Recognitions & Rankings of Venor Pharma
Contact details
Venor Pharma Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 43 Ground Floor G. T. Karnal Road Industrial Area, Delhi, India – 110033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Venor Pharma Limited, buy the company report.
Comprehensive company report
Venor Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Venor Pharma are manufacturing and hospital and medical care. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Venor Pharma Limited, buy the company report.
Financials of Venor Pharma Limited
FY 2024 filings availableVenor Pharma Limited reported revenue of ₹106.47 Cr (down 16% YoY) for FY 2025.
Revenue · FY 2025
₹106.47 Cr ▼ 16%
Net profit · FY 2025
₹16.41 Cr margin 15.4%
EBITDA · FY 2025
₹28.39 Cr margin 26.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 4%
5 years · compounded
▲ 82%
EBITDA CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 7%
5 years · compounded
▲ 95%
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 82%. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.41 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.7% | ||||
| Net Profit Margin | 15.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Venor Pharma Limited, buy the company report.
Board of directors of Venor Pharma Limited
Venor Pharma has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Verma | Director | 31 Aug 2018 | 8 Years 2 Months | Current |
| Yogesh Kapoor | Director | 08 Feb 2023 | 3 Years 9 Months | Current |
| Shivam Verma Also directs: Verxpo Pharma LLP | Director | 24 May 2023 | 3 Years 5 Months | Current |
| Vishwas Verma Also directs: Verve Health Care Limited | Director | 03 May 2013 | 13 Years 6 Months | Current |
| Ritesh Khetarpal | Director | 01 Jun 2024 | 2 Years 5 Months | Current |
| Savita Verma Also directs: Verve Health Care Limited, Saisha Homes LLP | Director | 03 May 2013 | 13 Years 6 Months | Current |
Peer comparison
Venor Pharma Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Formulations, Preventive Healthcare Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shiva Biogenetic Pharmaceuticals Private Limited | ₹107.81 Cr (FY 2025) | -23.0% | Solan, Himachal Pradesh, India | |||
| Shivalik Remedies Private Limited | ₹107.31 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Genetek Lifesciences Private Limited | ₹107.01 Cr (FY 2024) | 18.0% | Nagpur, Maharashtra, India | |||
| Venor Pharma Limitedthis company | ₹106.47 Cr (FY 2025) | ₹16.41 Cr | 15.4% | -16.0% | 283 | Delhi, India |
| Hi-Tech Formulations Private Limited | ₹105.6 Cr (FY 2025) | -16.0% | Chandigarh, India | |||
| Mediforce Healthcare Private Limited | ₹105.22 Cr (FY 2024) | 22.0% | Meerut, Uttar Pradesh, India | |||
| Suraksha Pharma Private Limited | ₹103.85 Cr (FY 2025) | 24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Venor Pharma Limited, buy the company report.
Auditor
Venor Pharma Limited is audited by DSP & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DSP & ASSOCIATES | FY 2023 | 006791N |
Shareholding
The shareholding of Venor Pharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Venor Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹49.58 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2023 | 100715044 | Others | ₹15 Cr | Open | |
| 20 Dec 2022 | 100709156 | Hdfc Bank Limited | ₹21.6 Cr | Open | |
| 02 Aug 2022 | 100601341 | Others | ₹12.98 Cr | Open |
To see the full charge records of Venor Pharma Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Venor Pharma Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2023.
Total deals
3
Secondary share transfers
2
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2020 | Rights issue | ₹5 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Venor Pharma Limited has 3 court cases on record: 2 filed by Venor Pharma, 1 filed against it. All cases are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Civil suit | Filed against the company by an individual | Disposed |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed by the company against Govt of NCT of Delhi | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Ors. | Disposed |
To see the full case history of Venor Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Venor Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Venor Pharma Limited has a workforce of 283 employees on its EPFO records as of May 2026.
Employee count
283
Employee growth
27.5%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 283 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Venor Pharma Limited, buy the company report.
GST
Venor Pharma has 14 GST registrations: 10 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
14
Active
10
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECV4893M1ZL | Delhi | Active | 14 Jul 2020 |
| 06AAECV4893M1ZN | Haryana | Active | 01 Jul 2017 |
| 29AAECV4893M1ZF | Karnataka | Active | 01 Jul 2017 |
| 22AAECV4893M1ZT | Chattisgarh | Active | 04 May 2018 |
To see the full GST registrations and return filing status of Venor Pharma Limited, buy the company report.
Recent activity
Venor Pharma Limited has 13 board changes on record since 2013: 6 appointments and 7 cessations. The latest: Ritesh Khetarpal ceased to be Additional Director on 29 Sep 2024.
AGM
Venor Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Ritesh Khetarpal ceased to be Additional Director.
Appointed
Ritesh Khetarpal was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 21.60 Cr registered on 20 Dec 2022 with Charge ID 100709156 was modified on 29 May 2024.
Filing
Venor Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Krishan Malhotra ceased to be Additional Director.
Ceased
Shivam Verma ceased to be Additional Director.
Ceased
Yogesh Kapoor ceased to be Additional Director.
Appointed
Shivam Verma was appointed as Director.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100715044 was registered on 11 May 2023.
Appointed
Yogesh Kapoor was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.60 Cr with Charge ID 100709156 was registered on 20 Dec 2022.
8 earlier events are in the company report.
Frequently asked questions
Venor Pharma is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 May 2013 (13+ years old) and is registered under CIN U74900DL2013PLC251565.
Venor Pharma has 6 current directors:
- Shubham Verma - Director
- Yogesh Kapoor - Director
- Shivam Verma - Director
- Vishwas Verma - Director
- Ritesh Khetarpal - Director
- Savita Verma - Director
The latest financial statements of Venor Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Venor Pharma is 07AAECV4893M1ZL, registered in Delhi. The company has 14 GST registrations in all, of which 10 are active and 4 are cancelled or inactive. Other active GSTINs include 06AAECV4893M1ZN (Haryana), 29AAECV4893M1ZF (Karnataka), 22AAECV4893M1ZT (Chattisgarh).
The CIN (Corporate Identification Number) of Venor Pharma is U74900DL2013PLC251565. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Venor Pharma has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the district courts.
Venor Pharma was incorporated on 03 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Venor Pharma has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2023.
The peers of Venor Pharma by revenue are Shiva Biogenetic Pharmaceuticals Private Limited, Shivalik Remedies Private Limited, Genetek Lifesciences Private Limited, Hi-Tech Formulations Private Limited, Mediforce Healthcare Private Limited and 1 more, all in the Healthcare industry (Formulations, Preventive Healthcare Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ritesh Khetarpal ceased to be Additional Director on 29 Sep 2024. Ritesh Khetarpal was appointed as Director on 01 Jun 2024. Krishan Malhotra ceased to be Additional Director on 31 Mar 2024. Venor Pharma has 13 board changes on record in total.
Yes, Venor Pharma is registered as an MSME under Udyam registration (number: UDYAM-UK-05-0008220).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages